News: Ministry of Environment,Forest and Climate Change, has made an amendment to EIA Notification 2006 to fasten availability/production of various drugs against COVID-19.
Facts:
- All projects or activities in respect of bulk drugs and intermediates, manufactured for addressing various ailments, have been re-categorized from the existing Category ‘A’ to ‘B2’ category.
- Projects falling under Category B2 are exempted from requirement of collection of Baseline data, EIA Studies and public consultation.
Additional Facts:
Environment Impact Assessment (EIA)
- EIA is a process which studies all aspects of the environment and seeks to anticipate the impact (positive and/or negative) of a proposed project or development on the environment.
- EIA is mandatory under the Environmental (Protection) Act, 1986 for 29 categories of developmental activities involving investments of Rs. 50 crores and above.
- Industrial Categorization:
- Industrial Sectors having Pollution Index score of 60 and above – Red category
- Industrial Sectors having Pollution Index score of 41 to 59 – Orange category
- Industrial Sectors having Pollution Index score of 21 to 40 – Green category
- Industrial Sectors having Pollution Index score incl.& upto 20 – White category
Note: The Pollution Index PI is a number from 0 to 100. Higher value of PI denotes the high degree of pollution load from the industrial sector. Pharmaceutical industry lies in the Red category.
